An object of the present invention is to provide a novel agent for treating, preventing or improving an inflammatory
disease or an allergic
disease. The present invention provides an agent for treating, preventing or improving an allergic
disease, or as an agent for treating, preventing or improving an inflammatory disease or an allergic disease, comprising, as an
active ingredient, (±) 5,6-dihydroxy-8Z,11Z,14Z,17Z-
eicosatetraenoic acid (5,6-DiHETE). The inflammatory disease can be an inflammatory disease due to an increase of
calcium concentration in vascular endothelial cells, and the inflammatory disease can be an inflammatory disease developed in a tissue or organ selected from the group consisting of digestive organs, circulatory organs, respiratory organs, urinary organs, genital organs, brain,
skin, eyes, and fat.